Intralipid/heparin
( DrugBank: Heparin / KEGG DRUG: Heparin sodium, Heparin calcium )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 316 | Carnitine cycle disorder | 1 |
| 317 | Trifunctional protein deficiency | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 344 | Very long-chain acyl-CoA dehydrogenase deficiency | 1 |
316. Carnitine cycle disorder
Clinical trials : 4 / Drugs : 5 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 10
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
317. Trifunctional protein deficiency
Clinical trials : 4 / Drugs : 6 - (DrugBank : 3) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
344. Very long-chain acyl-CoA dehydrogenase deficiency
Clinical trials : 6 / Drugs : 10 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 10
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|